📊 Score Breakdown
Offering Ability
100
Cash Runway
0
Float Risk
7
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
47%
🔄 Reverse Split
55%
• 50-day avg $0.31 below $1 exchange minimum
📉 Score Deterioration
40%
• Score rose 27 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($20M, 1064% of market cap)
• Active ATM program with $10M remaining capacity
💹 Market Data
Market Cap$1.88M
Shares Outstanding10.96M
Float10.74M
Cash$381.2K
Debt$6.35M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 39.7% shares (2025Q4 vs prior)
13 institutional holders · 151.4K shares
#1
CHOREO, LLC
34.2K shares
#2
CITADEL ADVISORS LLC
26.6K shares
#3
HRT FINANCIAL LP
24.3K shares
+ 10 more holders Sign up free to view →
📉 Short Interest
Short Interest215.6K
Days to Cover1.0
% of Float2.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Jun 15, 2021
8-K
8K EVENT
Apr 24, 2026
8-K
8K EVENT
Mar 12, 2026
3
FORM3
Feb 24, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for SBEV
📊 SBEV FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 SBEV Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.